Journal Report

DIABETES OBESITY & METABOLISM

Download PDF
Journal Information
Journal Title
DIABETES OBESITY & METABOLISM
Publisher
WILEY
ISSN
1462-8902
E-ISSN
1463-1326
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Beyond the Scale: Psychological and Behavioural Considerations Following <scp>GLP</scp> ‐1 Receptor Agonist Treatment Discontinuation
Alison K. Newman, Liana K. Billings
2026-11-3
Anthropometric, Muscle Function, Physical Activity, Inflammatory and Dietary Characteristics Associated With Fasting Glucose and Insulin Resistance in Rural and Urban Malawian Adults: A Cross‐Sectional Study
Shekinah Munthali‐Mkandawire, McDonald Chabwera, Louis Banda et al.
2026-11-3
Sleep Architecture, Glucose Regulation and Subclinical Cardiovascular Risk in Adults With Type 1 Diabetes Mellitus: A Wearable Sleep Tracking and Continuous Glucose Monitoring Study
Natália Marhefková, Viktória Mikušová, Robert Roland et al.
2026-11-3
Front Cover
Yutao Wang, Chuan‐Guo Guo, Yanhua Zhou et al.
2026-11-3 Vol. 28 Issue 12
Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation
Huilin Tang, Bingyu Zhang, Ying Lu et al.
2026-11-3
Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the <scp>FLOW</scp> Trial
Allon N. Friedman, Jan Basile, Robert Busch et al.
2026-11-3
β‐Cell Recovery Patterns With Initial Combination Versus Stepwise Therapy in Newly Diagnosed Type 2 Diabetes: <scp>TRIPLE</scp> ‐ <scp>AXEL</scp> Post Hoc Analysis
Il Rae Park, Jun Sung Moon, Joon Ha et al.
2026-11-3
Reproductive Outcome Registration in Phase 3 Weight‐Management Pharmacotherapy Trials: A Cross‐Sectional Meta‐Research Study
Rana Mondal, Mouli Nandi
2026-11-3
Bleeding and Thromboembolic Outcomes Following <scp>GLP</scp> ‐1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation
Fanxing Du, Brian Cicali, Naykky M. Singh Ospina et al.
2026-11-3
Therapeutic Signals Without Histologic Certainty: <scp>FGF</scp> Analogues in Compensated <scp>MASH</scp> Cirrhosis—A Systematic Review and Meta‐Analysis
Abdulkareem Jomaa, Mohammed Alani, Bilind Ismail et al.
2026-11-3
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 4, 2026 23:34